| Lot | A1657D |
|---|---|
| Concentration | 2.9 µg/µl |
| Species reactivity | Human, mouse, pig |
| Type | Polyclonal. ChIP-grade. ChIP-seq grade. CUT&Tag-grade.; |
| Purity | Affinity purified polyclonal antibody. |
| Host | Rabbit |
| Storage Conditions | Store at -20°C; for long storage, store at -80°C. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | PBS containing 0.05% azide and 0.05% ProClin 300. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Applications | Suggested dilution | References |
|---|---|---|
| ChIP/ChIP-seq * | 1-2 μg/IP | Fig 1, 2 |
| CUT&Tag | 1μg | Fig 3 |
| ELISA | 1:500 | Fig 4 |
| Dot Blotting | 1:10,000 | Fig 5 |
| Western Blotting | 1:500 | Fig 6 |
| Immunofluorescence | 1:500 | Fig 7 |
* Please note that the optimal antibody amount per IP should be determined by the end-user. We recommend testing 1-5 μg per IP.

Figure 1. ChIP results obtained with the antibody directed against H3K4me1
ChIP was performed with the antibody against H3K4me1 (cat. No. C15410037) on sheared chromatin from 500,000 HeLaS3 cells using the iDeal ChIP-seq kit (cat. No. C01010051). A titration of the antibody consisting of 0.5, 1, 2 and 5 µg per ChIP experiment was analysed. IgG (2 µg/IP) was used as negative IP control. Quantitative PCR was performed with primers for a region surrounding the ACTB and GAS2L1 genes, used as positive controls, and for the promoters of the GAPDH and EIF4A2 genes, used as negative controls. Figure 1 shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).

Figure 2. ChIP-seq results obtained with the antibody directed against H3K4me1
ChIP was performed as described above with 1 µg of the antibody against H3K4me1 (cat. No. C15410037). The IP’d DNA was subsequently analysed on an Illumina Genome Analyzer. Library preparation, cluster generation and sequencing were performed according to the manufacturer’s instructions. The 36 bp tags were aligned to the human genome using the ELAND algorithm. Figure 2A and B show the enrichment in chromosomal regions surrounding the ACTB and GAS2L1 positive control genes. The position of the amplicon used in the qPCR validation is indicated by an arrow. Figure 2C and D show the H3K4me1 signal in two 1 Mb regions of chromosome 5 and X, respectively.

Figure 3. Cut&Tag results obtained with the antibody directed against H3K4me1
Cut&Tag was performed on 50,000 K562 cells using 1 µg of the antibody against H3K4me1 (cat. No. C15410037) and the iDeal CUT&Tag kit (cat. No. C01070020). The libraries were subsequently analysed on an Illumina NovaSeq sequencer (2x50 bp paired-end reads) according to the manufacturer’s instructions. The tags were aligned to the human genome (hg38) using the BWA algorithm. Figure 3 shows the peak distribution in two genomic regions on chromosome 12 and 1 (figure 3A and B, respectively).

Figure 4. Determination of the titer
To determine the titer, an ELISA was performed using a serial dilution of the antibody directed against H3K4me1 (cat. No. C15410037) in antigen coated wells. The antigen used was a peptide containing the histone modification of interest. By plotting the absorbance against the antibody dilution (Figure 4), the titer of the antibody was estimated to be 1:20,100.

Figure 5.Cross reactivity tests using the antibody directed against H3K4me1
A Dot Blot analysis was performed to test the cross reactivity of the antibody against H3K4me1 (cat. No. C15410037) with peptides containing other modifications or unmodified sequences of histone H3. One hundred to 0.2 pmol of the respective peptides were spotted on a membrane. The antibody was used at a dilution of 1:10,000. Figure 5 shows a high specificity of the antibody for the modification of interest

Figure 6. Western blot analysis using the antibody directed against H3K4me1
Western blot was performed on whole cell (25 µg, lane 1) and histone extracts (15 µg, lane 2) from HeLa cells, and on 1 µg of recombinant histone H2A, H2B, H3 and H4 (lane 3, 4, 5 and 6, respectively) using the antibody against H3K4me1 (cat. No. C15410037). The antibody was diluted 1:500 in TBS-Tween containing 5% skimmed milk. The position of the protein of interest is shown on the right, the marker (in kDa) is shown on the left.

Figure 7. Immunofluorescence using the antibody directed against H3K4me1
HeLa cells were stained with the antibody against H3K4me1 (Cat. C15410037) and with DAPI. Cells were fixed with 4% formaldehyde for 10’ and blocked with PBS/TX-100 containing 5% normal goat serum and 1% BSA. The cells were immunofluorescently labeled with the H3K4me1 antibody (left) diluted 1:500 in blocking solution followed by an anti-rabbit antibody conjugated to Alexa488. The middle panel shows staining of the nuclei with DAPI. A merge of the two stainings is shown on the right.
Histones are the main constituents of the protein part of chromosomes of eukaryotic cells. They are rich in the amino acids arginine and lysine and have been greatly conserved during evolution. Histones pack the DNA into tight masses of chromatin. Two core histones of each class H2A, H2B, H3 and H4 assemble and are wrapped by 146 base pairs of DNA to form one octameric nucleosome. Histone tails undergo numerous post-translational modifications, which either directly or indirectly alter chromatin structure to facilitate transcriptional activation or repression or other nuclear processes. In addition to the genetic code, combinations of the different histone modifications reveal the so-called “histone code”. Histone methylation and demethylation is dynamically regulated by respectively histone methyl transferases and histone demethylases.
| ELISA Enzyme-linked immunosorbent assay. Read more |
| DB Dot blotting Read more |
| WB Western blot : The quality of antibodies used in this technique is crucial for correct and specific protein identification. Diagenode offers huge selection of highly sensitive and specific western blot-validated antibodies. Learn more about: Load... Read more |
| ChIP-seq (ab) Read more |
| ChIP-qPCR (ab) Read more |
| CUT&Tag The quality of antibody used in CUT&Tag is one of the crucial factors for assay success. The antibodies with confirmed high specificity will target only the protein of interest, enabling real results. Check out our selection of antibodies vali... Read more |
| Epigenetic Antibodies Brochure BROCHURE More than in any other immuoprecipitation assays, quality antibodies are critical tools in many e... | Download |
| Antibodies you can trust POSTER Epigenetic research tools have evolved over time from endpoint PCR to qPCR to the analyses of lar... | Download |
| Datasheet H3K4me1 C15410037 DATASHEET | Download |
| SDS C15410037 H3K4me1 Antibody US en | Download |
| SDS C15410037 H3K4me1 Antibody GB en | Download |
| SDS C15410037 H3K4me1 Antibody DE de | Download |
| SDS C15410037 H3K4me1 Antibody BE nl | Download |
| SDS C15410037 H3K4me1 Antibody JP ja | Download |
| SDS C15410037 H3K4me1 Antibody FR fr | Download |
| SDS C15410037 H3K4me1 Antibody ES es | Download |
| SDS C15410037 H3K4me1 Antibody BE fr | Download |
How to properly cite our product/service in your workWe strongly recommend using this: H3K4me1 Antibody (Hologic Diagenode Cat# C15410037 Lot# A1657D). Click here to copy to clipboard. Using our products or services in your publication? Let us know! |
Multimodal epigenetic and enhancer network remodeling shape the transcriptional landscape of human beige adipocytes |
Extrusion fountains are restricted by WAPL-dependent cohesin release and CTCF barriers |
Single-cell multi-omics, spatial transcriptomics and systematic perturbation decode circuitry of neural crest fate decisions |
KRAS promotes GLI2-dependent transcription during pancreatic carcinogenesis |
Chromatin profiling reveals TFAP4 as a critical transcriptional regulator of bovine satellite cell differentiation |
RUNX1 colludes with NOTCH1 to reprogram chromatin in T-cell acutelymphoblastic leukemia |
Incomplete transcriptional dosage compensation of vertebrate sexchromosomes is balanced by post-transcriptional compensation |
Gene Regulatory Interactions at Lamina-Associated Domains |
Repression and 3D-restructuring resolves regulatory conflicts inevolutionarily rearranged genomes. |
HOTAIR interacts with PRC2 complex regulating the regional preadipocytetranscriptome and human fat distribution. |
Local euchromatin enrichment in lamina-associated domains anticipatestheir repositioning in the adipogenic lineage. |
Loss of KMT2C reprograms the epigenomic landscape in hPSCsresulting in NODAL overexpression and a failure of hemogenic endotheliumspecification. |
Functional annotations of three domestic animal genomes provide vitalresources for comparative and agricultural research. |
Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis. |
Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia. |
The Itaconate Pathway Is a Central Regulatory Node Linking Innate Immune Tolerance and Trained Immunity |
Increased H3K9 methylation and impaired expression of Protocadherins are associated with the cognitive dysfunctions of the Kleefstra syndrome. |
A long range distal enhancer controls temporal fine-tuning of PAX6 expression in neuronal precursors. |
Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic Potential. |
Metabolic Induction of Trained Immunity through the Mevalonate Pathway. |
Krox20 hindbrain regulation incorporates multiple modes of cooperation between cis-acting elements |
A transcription factor pulse can prime chromatin for heritable transcriptional memory |
β-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance |
Enhancer decommissioning by Snail1-induced competitive displacement of TCF7L2 and down-regulation of transcriptional activators results in EPHB2 silencing |
cChIP-seq: a robust small-scale method for investigation of histone modifications |
C/EBPα Activates Pre-existing and De Novo Macrophage Enhancers during Induced Pre-B Cell Transdifferentiation and Myelopoiesis |
SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer. |
Interrogation of allelic chromatin states in human cells by high-density ChIP-genotyping. |
Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer |
A novel microscopy-based high-throughput screening method to identify proteins that regulate global histone modification levels. |
An In-Depth Characterization of the Major Psoriasis Susceptibility Locus Identifies Candidate Susceptibility Alleles within an HLA-C Enhancer Element. |
Disease-Related Growth Factor and Embryonic Signaling Pathways Modulate an Enhancer of TCF21 Expression at the 6q23.2 Coronary Heart Disease Locus. |
Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function. |
Characterization of the contradictory chromatin signatures at the 3' exons of zinc finger genes. |
Using ChIP-Seq Technology to Generate High-Resolution Profiles of Histone Modifications |